BNP PARIBAS ASSET MANAGEMENT Holding S.A. Boosts Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 12.8% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 120,149 shares of the company’s stock after purchasing an additional 13,618 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A.’s holdings in HCA Healthcare were worth $48,832,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Darsana Capital Partners LP grew its position in shares of HCA Healthcare by 53.3% in the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after buying an additional 400,000 shares during the last quarter. TD Asset Management Inc increased its position in shares of HCA Healthcare by 2.7% during the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock worth $238,110,000 after purchasing an additional 19,812 shares in the last quarter. Epoch Investment Partners Inc. grew its stake in HCA Healthcare by 16.4% during the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock worth $203,002,000 after buying an additional 88,948 shares during the last quarter. National Pension Service raised its stake in HCA Healthcare by 11.9% in the third quarter. National Pension Service now owns 550,654 shares of the company’s stock valued at $223,802,000 after buying an additional 58,353 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of HCA Healthcare by 2.3% during the second quarter. Dimensional Fund Advisors LP now owns 520,835 shares of the company’s stock worth $167,426,000 after acquiring an additional 11,861 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $332.22 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market cap of $84.15 billion, a PE ratio of 14.92, a PEG ratio of 1.29 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $245.84 and a one year high of $417.14. The firm has a fifty day moving average of $380.80 and a 200 day moving average of $357.94.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.79%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Insider Activity

In other news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock worth $5,608,990 over the last quarter. 1.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have weighed in on HCA shares. Truist Financial boosted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Oppenheimer increased their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Finally, TD Cowen dropped their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $385.00.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.